Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants - PubMed (original) (raw)
. 1994 Jun 2;369(6479):403-7.
doi: 10.1038/369403a0.
Affiliations
- PMID: 7515165
- DOI: 10.1038/369403a0
Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants
P Klenerman et al. Nature. 1994.
Abstract
Most asymptomatic individuals infected with HIV-1 have a cytotoxic T lymphocyte (CTL) response to the virus Gag proteins which can be demonstrated in vitro. Epitopes have been mapped in p17 Gag and p24 Gag restricted by HLA-B8 (p17-3 and p24-13) and -B27 (p24-14). Viruses isolated from patients who make CTL responses to these peptides vary within the genetic sequences encoding these epitopes and some mutations lead to reduction in killing activity in vitro. This was attributed to either failure of the variant epitope to bind major histocompatibility complex class I or failure of T-cell receptors to bind the presented peptide. But peptide variants of class I-restricted epitopes cause 'antagonism', that is, the presence of a variant epitope (in the form of peptide) inhibits normal lysis of targets presenting the original epitope. This mirrors similar findings in class II-restricted systems. Here we report that naturally occurring variant forms of p17-3, p24-13 and p24-14 may cause antagonism of CTL lines derived from the same individuals. The effect is present if the epitopes are derived from synthetic peptides and when they are processed from full-length proteins expressed by either recombinant vaccinia constructs or replicating HIV.
Comment in
- Promethean viruses?
Allen PM, Zinkernagel RM. Allen PM, et al. Nature. 1994 Jun 2;369(6479):355-6. doi: 10.1038/369355a0. Nature. 1994. PMID: 7515164 No abstract available.
Similar articles
- Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
Brander C, Yang OO, Jones NG, Lee Y, Goulder P, Johnson RP, Trocha A, Colbert D, Hay C, Buchbinder S, Bergmann CC, Zweerink HJ, Wolinsky S, Blattner WA, Kalams SA, Walker BD. Brander C, et al. J Virol. 1999 Dec;73(12):10191-8. doi: 10.1128/JVI.73.12.10191-10198.1999. J Virol. 1999. PMID: 10559335 Free PMC article. - HIV-1 variation diminishes CD4 T lymphocyte recognition.
Harcourt GC, Garrard S, Davenport MP, Edwards A, Phillips RE. Harcourt GC, et al. J Exp Med. 1998 Nov 16;188(10):1785-93. doi: 10.1084/jem.188.10.1785. J Exp Med. 1998. PMID: 9815256 Free PMC article. - Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein.
Buseyne F, McChesney M, Porrot F, Kovarik S, Guy B, Rivière Y. Buseyne F, et al. J Virol. 1993 Feb;67(2):694-702. doi: 10.1128/JVI.67.2.694-702.1993. J Virol. 1993. PMID: 7678303 Free PMC article. - Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.
O'Toole CM, Lowdell MW, Chargelegue D, Colvin BT. O'Toole CM, et al. AIDS Res Hum Retroviruses. 1992 Aug;8(8):1361-8. doi: 10.1089/aid.1992.8.1361. AIDS Res Hum Retroviruses. 1992. PMID: 1281655 - Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.
Goulder PJ, Brander C, Annamalai K, Mngqundaniso N, Govender U, Tang Y, He S, Hartman KE, O'Callaghan CA, Ogg GS, Altfeld MA, Rosenberg ES, Cao H, Kalams SA, Hammond M, Bunce M, Pelton SI, Burchett SA, McIntosh K, Coovadia HM, Walker BD. Goulder PJ, et al. J Virol. 2000 Jun;74(12):5679-90. doi: 10.1128/jvi.74.12.5679-5690.2000. J Virol. 2000. PMID: 10823876 Free PMC article.
Cited by
- CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides.
Gaud G, Achar S, Bourassa FXP, Davies J, Hatzihristidis T, Choi S, Kondo T, Gossa S, Lee J, Juneau P, Taylor N, Hinrichs CS, McGavern DB, François P, Altan-Bonnet G, Love PE. Gaud G, et al. Nat Immunol. 2023 Dec;24(12):2121-2134. doi: 10.1038/s41590-023-01663-2. Epub 2023 Nov 9. Nat Immunol. 2023. PMID: 37945821 Free PMC article. - HIV T-cell immunogen design and delivery.
Brander C, Hartigan-O'Connor D. Brander C, et al. Curr Opin HIV AIDS. 2022 Nov 1;17(6):333-337. doi: 10.1097/COH.0000000000000765. Epub 2022 Sep 19. Curr Opin HIV AIDS. 2022. PMID: 36165078 Free PMC article. Review. - Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants.
de Sousa E, Ligeiro D, Lérias JR, Zhang C, Agrati C, Osman M, El-Kafrawy SA, Azhar EI, Ippolito G, Wang FS, Zumla A, Maeurer M. de Sousa E, et al. Int J Infect Dis. 2020 Sep;98:454-459. doi: 10.1016/j.ijid.2020.07.016. Epub 2020 Jul 18. Int J Infect Dis. 2020. PMID: 32693089 Free PMC article. - Suboptimal stimulation by weak agonist epitope variants does not drive dysfunction of HIV-1-specific cytotoxic T lymphocyte clones.
Grossman MA, Hofmann C, Ng HL, Yang OO. Grossman MA, et al. AIDS. 2019 Aug 1;33(10):1565-1574. doi: 10.1097/QAD.0000000000002259. AIDS. 2019. PMID: 31306165 Free PMC article. - Comprehensive Review of Human _Plasmodium falciparum_-Specific CD8+ T Cell Epitopes.
Heide J, Vaughan KC, Sette A, Jacobs T, Schulze Zur Wiesch J. Heide J, et al. Front Immunol. 2019 Mar 21;10:397. doi: 10.3389/fimmu.2019.00397. eCollection 2019. Front Immunol. 2019. PMID: 30949162 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials